EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering Antibody Evolution: Germline‐Targeting HIV Vaccines Reach a Turning Point

Rowena A Bull iD, Deborah L Burnett iD

Immunology & Cell Biology · 2026-11 · 104 (10) · 1015-1018

DOI: 10.1111/imcb.70169 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology & Cell Biology, online erschienen am 06.10.2026. Verfasst von Rowena A Bull und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, UNSW Sydney, Kensington, New South Wales, Australia. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV Antibodies, Germ Cells, HIV Infections. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UNSW Faculty of Medicine, UNSW Triple I Seed Grant, Hillcrest Foundation and Perpetual Impact.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesHIV AntibodiesGerm CellsHIV InfectionsProtein EngineeringAnimalsHumansAntibodies, Neutralizing

Substanzen

AIDS VaccinesHIV AntibodiesAntibodies, Neutralizing

Autor:innen und Institutionen

  • School of Biomedical Sciences, UNSW Sydney, Kensington, New South Wales, Australia.
  • The Kirby Institute, UNSW Sydney, Kensington, New South Wales, Australia.
  • Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

ORCID-Profile: Rowena A Bull, Deborah L Burnett

Förderung

  • UNSW Faculty of Medicine
  • UNSW Triple I Seed Grant
  • Hillcrest Foundation and Perpetual Impact
  • Australian National Health and Medical Research Council (NHMRC)
  • National Health and Medical Research Council

Zitieren

APA

Bull, R. A., & Burnett, D. L. (2026). Engineering Antibody Evolution: Germline‐Targeting HIV Vaccines Reach a Turning Point. Immunology & Cell Biology, 104(10), 1015-1018. https://doi.org/10.1111/imcb.70169

Vancouver

Bull RA, Burnett DL. Engineering Antibody Evolution: Germline‐Targeting HIV Vaccines Reach a Turning Point. Immunology & Cell Biology. 2026;104(10):1015-1018. doi:10.1111/imcb.70169

BibTeX
@article{Bull2026,
  author = {Bull, Rowena A and Burnett, Deborah L},
  title = {Engineering Antibody Evolution: Germline‐Targeting HIV Vaccines Reach a Turning Point},
  journal = {Immunology & Cell Biology},
  year = {2026},
  volume = {104},
  number = {10},
  pages = {1015--1018},
  doi = {10.1111/imcb.70169}
}
Kostenlos starten →